Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups

NCT00711295 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3583

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: H5N1 Influenza Vaccine Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted
BIOLOGICAL: H5N1 Influenza Vaccine Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted

Sponsor

Alachua Government Services, Inc.